GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (FRA:29A) » Definitions » Cyclically Adjusted PB Ratio

Amphastar Pharmaceuticals (FRA:29A) Cyclically Adjusted PB Ratio : 2.26 (As of May. 22, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Amphastar Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2025-05-22), Amphastar Pharmaceuticals's current share price is €21.54. Amphastar Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €9.55. Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 2.26.

The historical rank and industry rank for Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:29A' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.17   Med: 4.3   Max: 6.79
Current: 2.23

During the past years, Amphastar Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 6.79. The lowest was 2.17. And the median was 4.30.

FRA:29A's Cyclically Adjusted PB Ratio is ranked worse than
59.15% of 656 companies
in the Drug Manufacturers industry
Industry Median: 1.76 vs FRA:29A: 2.23

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Amphastar Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2025 was €14.578. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €9.55 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Amphastar Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Amphastar Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 3.16 6.50 3.56

Amphastar Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.46 3.98 4.73 3.56 2.70

Competitive Comparison of Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Amphastar Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=21.54/9.55
=2.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amphastar Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Amphastar Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=14.578/134.9266*134.9266
=14.578

Current CPI (Mar. 2025) = 134.9266.

Amphastar Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201506 5.607 100.684 7.514
201509 5.593 100.392 7.517
201512 6.002 99.792 8.115
201603 5.926 100.470 7.958
201606 6.069 101.688 8.053
201609 6.357 101.861 8.421
201612 6.749 101.863 8.940
201703 6.623 102.862 8.688
201706 6.414 103.349 8.374
201709 6.045 104.136 7.832
201712 6.049 104.011 7.847
201803 5.686 105.290 7.287
201806 5.911 106.317 7.502
201809 5.930 106.507 7.512
201812 6.266 105.998 7.976
201903 6.294 107.251 7.918
201906 7.269 108.070 9.075
201909 7.491 108.329 9.330
201912 7.369 108.420 9.171
202003 7.378 108.902 9.141
202006 7.435 108.767 9.223
202009 7.238 109.815 8.893
202012 6.963 109.897 8.549
202103 7.139 111.754 8.619
202106 7.299 114.631 8.591
202109 7.620 115.734 8.884
202112 8.263 117.630 9.478
202203 8.931 121.301 9.934
202206 9.641 125.017 10.405
202209 10.495 125.227 11.308
202212 10.373 125.222 11.177
202303 10.635 127.348 11.268
202306 11.140 128.729 11.676
202309 11.642 129.860 12.096
202312 12.198 129.419 12.717
202403 12.665 131.776 12.968
202406 13.535 132.554 13.777
202409 13.554 133.029 13.747
202412 14.687 133.157 14.882
202503 14.578 134.927 14.578

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amphastar Pharmaceuticals  (FRA:29A) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Amphastar Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amphastar Pharmaceuticals Business Description

Traded in Other Exchanges
Address
11570 6th Street, Rancho Cucamonga, CA, USA, 91730
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Amphastar Pharmaceuticals Headlines

No Headlines